LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling.
Ling YouYanjie ZhengJing YangQian HouLianxia WangYan ZhangChunxia ZhaoRuiqin XiePublished in: Mediators of inflammation (2022)
In summary, MDRL alleviates NLRP3 inflammasome activation and apoptosis in VSMCs through miR-361/SQSTM1/NLRP3 pathway during atherogenesis. These data indicate that MDRL and inhibition of miR-361 represent potential therapeutic targets in atherosclerosis-related diseases.